Zicai H. Liang

5 Yiheyuan Rd
Beijing, 100871, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

RNA interference therapy targeting coagulation factor XI: a first-in-human trial of RBD4059 (vortosiran).

RNA interference therapy targeting coagulation factor XI: a first-in-human trial of RBD4059 (vortosiran).

Journal: Blood advances

Published: September 09, 2025

Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation.

Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation.

Journal: Nature communications

Published: June 19, 2025

A potent GalNAc-siRNA drug, RBD1016, leads to sustained HBsAg reduction and seroconversion in mouse models of HBV infection.

A potent GalNAc-siRNA drug, RBD1016, leads to sustained HBsAg reduction and seroconversion in mouse models of HBV infection.

Journal: Molecular therapy. Nucleic acids

Published: December 04, 2024

Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic Effects.

Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic Effects.

Journal: JACC. Basic to translational science

Published: September 11, 2024

Publisher Correction to: ISIS 449884 Injection Add‑On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double‑Blind, Placebo‑Controlled, Phase II Clinical Study.

Publisher Correction to: ISIS 449884 Injection Add‑On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double‑Blind, Placebo‑Controlled, Phase II Clinical Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: August 29, 2024

ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study.

ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: May 22, 2024

The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study.

The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study.

Journal: Diabetes, obesity & metabolism

Published: May 09, 2024

Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014

Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: March 18, 2024

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B.

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B.

Journal: Signal transduction and targeted therapy

Published: August 07, 2021

20-MHz phased array ultrasound transducer for in vivo ultrasound imaging of small animals.

20-MHz phased array ultrasound transducer for in vivo ultrasound imaging of small animals.

Journal: Ultrasonics

Published: May 07, 2021

Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA.

Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA.

Journal: Nano letters

Published: February 18, 2021

Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle.

Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle.

Journal: Bioactive materials

Published: May 27, 2020

Showing 1-12 of 68

Last Updated: 09/26/2026